Ashwani K. Dhingra, “The future of cancer immunotherapy: Advances in checkpoint inhibitors and chimeric antigen receptor-T cells discussing recent progress in immunotherapy for cancer, focusing on checkpoint inhibitors and chimeric antigen receptor-T cell therapies”, Inn Phar Plan, vol. 12, no. 4, pp. 69–72, Dec. 2024.